Login / Signup

Methods for addressing "innocent bystanders" when evaluating safety of concomitant vaccines.

Shirley V WangAbdurrahman AbdurrobJulia SpoendlinEdwin LewisSophia R NewcomerBruce FiremanMatthew F DaleyJason M GlanzJonathan DuffyEric S WeintraubMartin Kulldorff
Published in: Pharmacoepidemiology and drug safety (2018)
We have shown that when using a self-controlled design to investigate safety of concomitant vaccination, it can be critically important to adjust for time-invariant effect modifying risk factors, such as age at time of vaccination, which are structurally related to vaccination patterns due to recommended immunization schedules.
Keyphrases
  • risk factors